CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on producing biopharmaceutical proteins in plants as a cost-effective alternative to mammalian cell systems. It aims to develop methods for creating antibody cocktails against diseases like HIV and rabies, facilitating access to essential medicines.
Biopharmaceutical proteins are typically produced in cultivated mammalian cells, a costly process with limited scalability.
Thus products such as monoclonal antibodies are very expensive and often beyond the reach of the world’s poor.
The problem is compounded by the fact that important strategies for preventing diseases such as HIV and rabies typically involve large doses of multiple antibodies and other virucidal proteins.
Plants have emerged as alternative production platforms for biopharmace…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Aachen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
